GlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...

Republican leader Donald Trump issued the brutal remark whilst discussing diabetes medications used for weight loss ...

Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.